The Consortium for Biomedical Research and Artificial Intelligence in Neurodegeneration (C-BRAIN) launched three open-source AI tools to accelerate research aimed at “developing new treatments for Alzheimer’s disease and other neurodegenerative diseases.”

The tools are used to “synthesize Alzheimer’s and neuroscience literature, surface insights from unpublished and so called ‘dark’ or hidden data, and provide peer review-style feedback for researchers.” They are also meant to try to understand why “more than 99% of Alzheimer’s drug candidates fail in clinical trials,” reducing fragmentation of research across millions of published papers and unpublished research results.

The consortium’s federated design “lets members keep full control of their own data. Proprietary and unpublished pharmaceutical data can inform the tools without being exposed or transferred, and a scientist-in-the-loop approach keeps human researchers involved at every stage.”

All three tools are “freely available to biomedical researchers working in the field of neurodegeneration, who can register for approval by contacting C-BRAIN. A demonstration of the tools’ capabilities is also publicly available on the consortium’s website.”